Patents-Review.com
ClassID:

111250 ⎘

C12N2770/20021 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Coronaviridae Viruses as such, e.g. new isolates, mutants or their genomic sequences

Recent Application in this class:
#1
20260108596
2026-04-23

NOBLE COLD-ADAPTED ATTENUATED MERS-COV

 #2
20250387467
2025-12-25

SARS-COV-2 LACKING THE ENVELOPE PROTEIN AS AN ATTENUATED VACCINE VIRUS AGAINST COVID-19

 #3
20250327039
2025-10-23

VIRAL PREPARATIONS AND METHODS FOR TREATING AND MODULATING MITOCHONDRIAL EFFECTS OF CORONAVIRUS INFECTIONS.

 #4
20250295756
2025-09-25

LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF

 #5
20250250647
2025-08-07

STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA

 #6
20250161431
2025-05-22

ATTENUATED SARS-COV-2

 #7
20250066752
2025-02-27

CRISPR-BASED PROGRAMMABLE RNA EDITING

 #8
20250032604
2025-01-30

IMMUNOGENIC COMPOSITIONS AND THEIR USES

 #9
20240299533
2024-09-12

DEOPTIMIZED SARS-COV-2 VARIANTS AND METHODS AND USES THEREOF

 #10
20240285752
2024-08-29

Attenuated Porcine Epidemic Diarrhea Virus

 #11
20240254203
2024-08-01

ANTIBODY-BASED ANTIVIRUS COMPOSITIONS AND METHODS OF USE

 #12
20230416692
2023-12-28

REVERSE GENETIC SYSTEM FOR SARS-COV-2

 #13
20230393122
2023-12-07

STEM CELL COMPOSITIONS FOR CULTURING CORONAVIRUSES AND METHODS OF MAKING AND USING THEREOF

 #14
20230340423
2023-10-26

METHOD OF PRODUCING MODIFIED VIRUS GENOMES AND PRODUCING MODIFIED VIRUSES

 #15
20230174953
2023-06-08

DEFECTIVE INTERFERING VIRAL GENOMES

 #16
20230151367
2023-05-18

THERAPEUTIC INTERFERING PARTICLES FOR CORONA VIRUS

 #17
20230040061
2023-02-09

CRISPR-based programmable RNA editing

 #18
20220347284
2022-11-03

NOVEL FISH CORONAVIRUS

 #19
20220265815
2022-08-25

Method of treating or preventing clinical signs caused by infectious bronchitis virus with 4/91 IBV vaccine having heterologous spike protein

 #20
20220208325
2022-06-30

Computational reduction vaccine for Covid-19 originating from Civet Sars, Bat Sars, BetaCov btrs, BetaCov BtRI, and Neoromicia

 #21
20220204568
2022-06-30

METHOD FOR RAPID PREPARATION OF EPIDEMIC INFECTIOUS BRONCHITIS VACCINE

 #22
20210403880
2021-12-30

Computational reduction vaccine for Covid-19 BIN100

 #23
20210315989
2021-10-14

Methods to prepare nasopharyngeal and oral material for oral inoculation of COVID-19

 #24
20210302434
2021-09-30

SARS-CoV-2 surrogate virus neutralization assay test kit

 #25
20210246431
2021-08-12

Human Betacoronavirus Lineage C and Identification of N-Terminal Dipeptidyl Peptidase As Its Virus Receptor

 #26
20210115410
2021-04-22

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

 #27
20200332373
2020-10-22

Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays

 #28
20200325182
2020-10-15

Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods

 #29
20200129614
2020-04-30

H52 IBV vaccine with heterologous spike protein

 #30
20200129613
2020-04-30

4/91 IBV vaccine with heterologous spike protein

 #31
20190022214
2019-01-24

Attenuated infectious bronchitis virus

 #32
20190008950
2019-01-10

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

 #33
20180216082
2018-08-02

Live attenuated Arkansas serotype infectious bronchitis virus vaccine

 #34
20180207260
2018-07-26

Porcine epidemic diarrhea virus vaccine

 #35
20180104328
2018-04-19

POULTRY VIRUS VACCINES THAT ARE LIQUID STABLE

 #36
20180066236
2018-03-08

IBV strains and uses thereof

 #37
20170274065
2017-09-28

Attenuated bovine coronavirus and related vaccines

 #38
20170216427
2017-08-03

Coronavirus

 #39
20170096644
2017-04-06

IBV strains and uses thereof

 #40
20160346381
2016-12-01

Poultry virus vaccines that are liquid stable

 #41
20160296617
2016-10-13

Immunogenic composition for MERS coronavirus infection

 #42
20160060303
2016-03-03

Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

 #43
20160032253
2016-02-04

Attenuation of infectious bronchitis virus variant GA-13

 #44
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #45
20150283229
2015-10-08

Porcine epidemic diarrhea virus vaccine

 #46
20150275183
2015-10-01

Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor

 #47
20150050308
2015-02-19

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

 #48
20140205621
2014-07-24

Canine coronavirus vaccine

 #49
20120039921
2012-02-16

Poultry viral materials and methods related thereto

 #50
20110097353
2011-04-28

POULTRY VIRAL MATERIALS AND METHODS RELATED THERETO

 #51
20110065091
2011-03-17

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

 #52
20100184019
2010-07-22

Human virus causing severe acute respiratory syndrome (SARS) and uses thereof

 #53
20100080824
2010-04-01

Human virus causing severe acute respiratory syndrome (SARS) and uses thereof

 #54
20090305282
2009-12-10

Human virus causing respiratory tract infection and uses thereof

 #55
20080069839
2008-03-20

Isolation and characterization of the precursor virus of human SARS virus: SARS-associated corona virus-like virus

 #56
20080069838
2008-03-20

Human virus causing severe acute respiratory syndrome (SARS) and uses thereof

 #57
20080044426
2008-02-21

Novel Atypical Pneumonia-Causing Virus

 #58
20070258999
2007-11-08

SARS virus nucleotide and amino acid sequences and uses thereof

 #59
20070053878
2007-03-08

Sars

 #60
20060257852
2006-11-16

Severe acute respiratory syndrome coronavirus

 #61
20060034853
2006-02-16

Human virus causing respiratory tract infection and uses thereof

 #62
20060024668
2006-02-02

Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics

 #63
20060018923
2006-01-26

Human virus causing respiratory tract infection and uses thereof

 #64
20060003319
2006-01-05

Compositions and methods for determining resistance to inhibitors of virus entry using recombinant virus assays

 #65
20050214748
2005-09-29

Peptide-based diagnostic reagents for SARS

 #66
20050186575
2005-08-25

Corona-virus-like particles comprising functionally deleted genomes

 #67
20050130127
2005-06-16

Coronavirus-like particles comprising functionally deleted genomes

 #68
20050112554
2005-05-26

Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof

 #69
17368994
2025-05-13

Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections